Clinical Trials in Milan, MI
2 recruiting
Showing 1–20 of 20 trials
Recruiting
Phase 1
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Non-small Cell Lung CancerPancreatic Ductal AdenocarcinomaHR+/HER2- Ductal and Lobular Breast Cancer
Novartis Pharmaceuticals162 enrolled30 locationsNCT06562192
Recruiting
Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC
HER2NSCLC (Advanced Non-small Cell Lung Cancer)
Gruppo Oncologico Italiano di Ricerca Clinica50 enrolled22 locationsNCT07356544
Recruiting
Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
San Raffaele University1,200 enrolled4 locationsNCT07450612
Recruiting
Phase 1Phase 2
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis Pharmaceuticals188 enrolled18 locationsNCT07206056
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled140 locationsNCT05939414
Recruiting
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Novartis Pharmaceuticals300 enrolled32 locationsNCT07093801
Recruiting
Phase 1Phase 2
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid Tumors
Novartis Pharmaceuticals280 enrolled30 locationsNCT06726148
Recruiting
Duodenal Polyposis Classification in FAP
Familial Adenomatous PolyposisFAPDuodenal Neoplasms+6 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano300 enrolled2 locationsNCT07199127
Recruiting
ALFAOMEGA Master Observational Trial
IFOM ETS - The AIRC Institute of Molecular Oncology3,000 enrolled19 locationsNCT04120935
Recruiting
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
IFOM ETS - The AIRC Institute of Molecular Oncology500 enrolled13 locationsNCT05101382
Recruiting
Phase 1Phase 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Metastatic Solid TumorsLocally Advanced Solid Tumors
Turning Point Therapeutics, Inc.500 enrolled165 locationsNCT03093116
Recruiting
Not Applicable
24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer
Localized Prostate Carcinoma
IRCCS San Raffaele70 enrolled1 locationNCT05936736
Recruiting
International Prospective REgistry on Pre-pectorAl Breast REconstruction
Breast Cancer
IRCCS San Raffaele1,236 enrolled11 locationsNCT05817175
Recruiting
Whole Body MRI in Oncology
Advanced Breast CancerAdvanced Prostate CancerMultiple Myeloma+3 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1,000 enrolled3 locationsNCT06895291
Recruiting
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Hereditary Cancer SyndromeHereditary CancerLynch Syndrome+19 more
San Raffaele University300 enrolled5 locationsNCT06708429
Recruiting
Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
European Institute of Oncology30 enrolled1 locationNCT06706557
Recruiting
PIK3CA Mutational Status Assessment
Breast Cancer Metastatic
European Institute of Oncology100 enrolled1 locationNCT06706570
Recruiting
All-in-One Prostate Cancer Staging with MRI
Prostate Cancer
European Institute of Oncology400 enrolled3 locationsNCT06071195
Recruiting
Not Applicable
Lung Cancer Prevention Screening Programme in Italy
Lung CancerCardiovascular DiseasesCOPD (Chronic Obstructive Pulmonary Disease) With Acute Lower Respiratory Infection
Ugo Pastorino7,324 enrolled1 locationNCT05766046
Recruiting
Not Applicable
DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano50,000 enrolled1 locationNCT05057598